Chrishan S Samuel (Chrishan Samuel, Andrew W Stent)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 20

Top Topics

Pulmonary Fibrosis

Top Venues

British journal of pharmacology

International journal of molecular sciences

Canadian respiratory journal

This page only lists publications with an associated author ORCID identifier.

Publications

Praveen Praveen, Chao Wang, Thomas N G Handley, Hongkang Wu, Chrishan S Samuel, Ross A D Bathgate, Mohammed Akhter Hossain
A Lipidated Single-B-Chain Derivative of Relaxin Exhibits Improved In Vitro Serum Stability without Altering Activity. International journal of molecular sciences 24 (7) (2023)
Udari Eshani Perera, Louise Organ, Simon G Royce, Chrishan S Samuel, Habtamu B Derseh, Sasika N V Dewage, Emmanuel Koumoundouros, Andrew W Stent, Kenneth J Snibson
Comparative Study of Ectopic Lymphoid Aggregates in Sheep and Murine Models of Bleomycin-Induced Pulmonary Fibrosis. Canadian respiratory journal 2023 (2023)
Udari Eshani Perera, Louise Organ, Simon G Royce, Chrishan S Samuel, Habtamu B Derseh, Sasika N V Dewage, Emmanuel Koumoundouros, Andrew W Stent, Kenneth J Snibson
Comparative Study of Ectopic Lymphoid Aggregates in Sheep and Murine Models of Bleomycin-Induced Pulmonary Fibrosis. Canadian respiratory journal 2023 (2023)
Udari Eshani Perera, Louise Organ, Simon G Royce, Chrishan S Samuel, Habtamu B Derseh, Sasika N V Dewage, Emmanuel Koumoundouros, Andrew W Stent, Kenneth J Snibson
Comparative Study of Ectopic Lymphoid Aggregates in Sheep and Murine Models of Bleomycin-Induced Pulmonary Fibrosis. Canadian respiratory journal 2023 (2023)
Amrilmaen Badawi, Osfred C Jefferson, Brooke M Huuskes, Sharon D Ricardo, Peter G Kerr, Chrishan S Samuel, Padma Murthi
A Novel Approach to Enhance the Regenerative Potential of Circulating Endothelial Progenitor Cells in Patients with End-Stage Kidney Disease. Biomedicines 10 (4) (2022)
Felipe Tapia Cáceres, Tracey A Gaspari, Mohammed Akhter Hossain, Chrishan S Samuel
Relaxin Inhibits the Cardiac Myofibroblast NLRP3 Inflammasome as Part of Its Anti-Fibrotic Actions via the Angiotensin Type 2 and ATP (P2X7) Receptors. International journal of molecular sciences 23 (13) (2022)
Irvan Alfian, Amlan Chakraborty, Hannah Ee Juen Yong, Sheetal Saini, Ricky W K Lau, Bill Kalionis, Evdokia Dimitriadis, Nadia Alfaidy, Sharon D Ricardo, Chrishan S Samuel, Padma Murthi
The Placental NLRP3 Inflammasome and Its Downstream Targets, Caspase-1 and Interleukin-6, Are Increased in Human Fetal Growth Restriction: Implications for Aberrant Inflammation-Induced Trophoblast Dysfunction. Cells 11 (9) (2022)
Yan Wang, Jonathan Yodgee, Mark Del Borgo, Iresha Spizzo, Levi Nguyen, Marie-Isabel Aguilar, Kate M Denton, Chrishan S Samuel, Robert E Widdop
The Novel AT2 Receptor Agonist β-Pro7-AngIII Exerts Cardiac and Renal Anti-Fibrotic and Anti-Inflammatory Effects in High Salt-Fed Mice. International journal of molecular sciences 23 (22) (2022)
Chrishan S Samuel, Yifang Li, Yan Wang, Robert E Widdop
Functional crosstalk between angiotensin receptors (types 1 and 2) and relaxin family peptide receptor 1 (RXFP1): Implications for the therapeutic targeting of fibrosis. British journal of pharmacology (2022)
Chrishan S Samuel, Yifang Li, Yan Wang, Robert E Widdop
AT 1 R-AT 2 R-RXFP1 functional crosstalk: implications for the therapeutic targeting of fibrosis. British journal of pharmacology (2022)
Yifang Li, Sharon D Ricardo, Chrishan S Samuel
Enhancing the Therapeutic Potential of Mesenchymal Stromal Cell-Based Therapies with an Anti-Fibrotic Agent for the Treatment of Chronic Kidney Disease. International journal of molecular sciences 23 (11) (2022)
Yifang Li, Matthew Shen, Dorota Ferens, Brad R S Broughton, Padma Murthi, Sheetal Saini, Robert E Widdop, Sharon D Ricardo, Anita A Pinar, Chrishan S Samuel
Combining mesenchymal stem cells with serelaxin provides enhanced renoprotection against 1K/DOCA/salt-induced hypertension. British journal of pharmacology 178 (5) (2021)
Giannie Barsha, Sarah L Walton, Edmund Kwok, Katrina M Mirabito Colafella, Anita A Pinar, Lucinda M Hilliard Krause, Tracey A Gaspari, Robert E Widdop, Chrishan S Samuel, Kate M Denton
Relaxin Attenuates Organ Fibrosis via an Angiotensin Type 2 Receptor Mechanism in Aged Hypertensive Female Rats. Kidney360 2 (11) (2021)
Ishant Khurana, Scott Maxwell, Simon G Royce, Prabhu Mathiyalagan, Tom C Karagiannis, Nadia Mazarakis, Jitraporn Pimm Vongsvivut, Harikrishnan Kaipananickal, Jun Okabe, Keith Al-Hasani, Chrishan S Samuel, Assam El-Osta
SAHA attenuates Takotsubo-like myocardial injury by targeting an epigenetic Ac/Dc axis. Signal transduction and targeted therapy 6 (1) (2021)
Chao Wang, Tracey A Gaspari, Dorota Ferens, Iresha Spizzo, Barbara K Kemp-Harper, Chrishan S Samuel
Simultaneous targeting of oxidative stress and fibrosis reverses cardiomyopathy-induced ventricular remodelling and dysfunction. British journal of pharmacology 178 (12) (2021)
Sadman Bhuiyan, Matthew Shen, Sharenya Chelvaretnam, Andre Y Tan, Gideon Ho, Mohammed Akhter Hossain, Robert E Widdop, Chrishan S Samuel
Assessment of renal fibrosis and anti-fibrotic agents using a novel diagnostic and stain-free second-harmonic generation platform. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 35 (5) (2021)
Yan Wang, Miao Wang, Chrishan S Samuel, Robert E Widdop
Preclinical rodent models of cardiac fibrosis. British journal of pharmacology (2021)
Sasika N V Dewage, Louise Organ, Emmanuel Koumoundouros, Habtamu B Derseh, Kopiyawaththage U E Perera, Chrishan S Samuel, Chrishan S Samuel, Ken J Snibson
The efficacy of pirfenidone in a sheep model of pulmonary fibrosis. Experimental lung research 45 (9-10) (2019)
Caitlin V Lewis, Antony Vinh, Henry Diep, Chrishan S Samuel, Grant R Drummond, Barbara K Kemp-Harper
Distinct Redox Signalling following Macrophage Activation Influences Profibrotic Activity. Journal of immunology research 2019 (2019)
Simon G Royce, Krupesh P Patel, WeiYi Mao, Dandan Zhu, Rebecca Lim, Chrishan S Samuel
Serelaxin enhances the therapeutic effects of human amnion epithelial cell-derived exosomes in experimental models of lung disease. British journal of pharmacology 176 (13) (2019)